An Official Website of the United States Government
Company Information:
Name:
PRIMORIGEN BIOSCIENCES, LLC
Address:
510 CHARMANY DRIVE
MADISON, WI 53719-
MADISON, WI 53719-
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Novel Assay for Rapid Antibody Screening
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Award Amount:
$362,714.00
Abstract:
DESCRIPTION (provided by applicant): Primorigen Biosciences will use Phase I SBIR funds to develop a frameless, multiplexed, microarray screening system for rapid identification and characterization of antibody matched pairs with appropriate affinity and
specificity for target proteins. This… More
A Novel Multiplexed Assay for Rapid Antibody Screening
Award Year / Program / Phase:
2010 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Scott A. Monsma
Award Amount:
$1,569,693.00
Abstract:
DESCRIPTION (provided by applicant): Primorigen Biosciences will use Phase II SBIR funds to accelerate and expand the development of new regenerative medicine cell therapies by developing a novel high throughput, low cost protein quantification system for
characterizing pancreatic 2 cell and islet… More
New Multiplexed Quantitative Detection of Pluripotency and Germ Layer Proteins
Award Year / Program / Phase:
2010 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Scott A. Monsma
Award Amount:
$1,395,253.00
Abstract:
DESCRIPTION (provided by applicant): Primorigen Biosciences will use Phase II SBIR funds to accelerate and expand the development of new regenerative medicine cell therapies by developing a novel high throughput, low cost protein quantification system for characterizing pluripotent cell lines and… More
A Novel System for Mass Production of iPS Cells
Award Year / Program / Phase:
2011 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Scott A. Monsma – 608-441-8331
Award Amount:
$343,865.00
Abstract:
DESCRIPTION (provided by applicant): Primorigen Biosciences LLC SBIR Project Abstract Primorigen will use SBIR funds to develop and validate a microcarrier-based cell culture system for selection, scale-up and feeder-free mass production of iPS cells, based on Primorigen's proprietary… More
A Novel Method to Improve Function of SC-Derived Hepatocytes
Award Year / Program / Phase:
2012 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Scott A. Monsma – 608-441-8332
Award Amount:
$328,224.00
Abstract:
DESCRIPTION (provided by applicant): Primorigen Biosciences SBIR Proposal Abstract Primorigen Biosciences will use SBIR funds to develop an advanced cell culturing methodology to increase the efficiency of directed differentiation and to boost functional maturity of induced pluripotent stem… More
A Novel Method to Improve Proliferation and Neural Induction of Human MSCs
Award Year / Program / Phase:
2012 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Bradley H. Garcia – 608-441-8332
Award Amount:
$344,715.00
Abstract:
DESCRIPTION (provided by applicant): Primorigen Biosciences will develop an enhanced cell culturing technology that dramatically increases proliferative and differentiation capabilities of human bone-marrow derived mesenchymal stem cells (hMSC's) for neural induction, and ultimately for… More